4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-008047
Exec. Director, Finance - PAO sold 2,300 shares at $17.20 ($39,560)
- Exec. Director, Finance - PAO acquired 2,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jones Michael L · Exec. Director, Finance - PAO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Exercise or conversion : show line 1 in the form | +2,300 | $4.73 | $10,879 | 13,498 | D |
| 2022-03-01 | Sale : show line 2 in the form | −2,300 | $17.20 | $39,560 | 11,198 | D |
| Open-market sales · 2,300 sh · avg $17.20 · $39,560 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −2,300 | 0 | D |
Loading xslF345X03/form4.xml…